Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-15-000835
Filing Date
2015-03-13
Accepted
2015-03-13 17:31:19
Documents
11
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 form10k.htm 10-K 1445664
2 ex31-1.htm EX-31.1 10726
3 ex31-2.htm EX-31.2 11203
4 ex32-1.htm EX-32.1 7306
5 ex32-2.htm EX-32.2 7356
  Complete submission text file 0001493152-15-000835.txt   6739380

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cdxi-20141231.xml EX-101.INS 688767
7 XBRL SCHEMA FILE cdxi-20141231.xsd EX-101.SCH 61395
8 XBRL CALCULATION FILE cdxi-20141231_cal.xml EX-101.CAL 66140
9 XBRL DEFINITION FILE cdxi-20141231_def.xml EX-101.DEF 222609
10 XBRL LABEL FILE cdxi-20141231_lab.xml EX-101.LAB 437210
11 XBRL PRESENTATION FILE cdxi-20141231_pre.xml EX-101.PRE 338704
Mailing Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822
Business Address 2800 WOODLAWN DRIVE SUITE 129 HONOLULU HI 96822 808-457-1400
CARDAX, INC. (Filer) CIK: 0001544238 (see all company filings)

EIN.: 454484428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 333-181719 | Film No.: 15700453
SIC: 2834 Pharmaceutical Preparations